2002

1. Atorvastatin reduces expression of the CCR2 and MAC-1 receptors on monocytes, and plasma levels of monocyte chemoattractant protein-1 and C-reactive protein, in patients with coronary heart disease

   Clinical Drug Investigation, Vol. 22, Núm. 1, pp. 1-8